Sanofi – Filings and Transcripts

NASDAQ: SNY
Share price (4/24/26): $46.78
Market cap (4/24/26): $114 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

Prospectuses and Registrations Filter

Registration of securities for employees

Third party tender offer – amended

Amendment to registration of securities for employees

Third party tender offer – amended

Third party tender offer – amended

Ownership Filter

Holdings report

Holdings report

News Filter

ESCMID: Sanofi’s Nuvaxovid COVID-19 Vaccine Showed Better Tolerability Than mNEXSPIKE in Head-To-Head Study

Q1 2026: Double-Digit Sales and Business EPS Growth

Lunsekimig Met Primary and Key Secondary Endpoints in Phase 2 Respiratory Studies in Asthma and CRSwNP

Sanofi and Regeneron’s Dupixent Approved in Japan as the First Targeted Medicine to Treat Adults With Bullous Pemphigoid

Venglustat Earns Breakthrough Therapy Designation in the US for Type 3 Gaucher Disease

Proxies Filter

Annual report of proxy voting record

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Proxy in contested situation

Other Filter

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Conflict Minerals disclosure

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Conflict Minerals disclosure

Correspondence with the SEC